Home › Atherosclerosis › Illinois › Naperville
Atherosclerosis clinical trials in Naperville, IL
3 studies for Atherosclerosis are looking for participants at sites in and around Naperville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Accellacare - DuPage, Lombard · 10 mi away
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Accellacare - DuPage, Lombard · 10 mi away
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Winfield · 5 mi away
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA9 studies
- Houston, TX7 studies
- Washington, DC7 studies
- Durham, NC6 studies
- Hialeah, FL6 studies
- San Diego, CA5 studies
- Santa Monica, CA5 studies
- Minneapolis, MN5 studies
- Omaha, NE5 studies
- Dallas, TX5 studies
- Memphis, TN5 studies
- Tucson, AZ5 studies
Other studies in Naperville
- Non-Small Cell Lung Cancer15 studies
- Lung Cancer13 studies
- Heart Failure11 studies
- Breast Cancer10 studies
- Prostate Cancer10 studies
- Cardiovascular Disease8 studies
- Pancreatic Cancer6 studies
- Macular Degeneration6 studies
- Geographic Atrophy6 studies
- Colon Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Atrial Fibrillation5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.